Search results
Should You Buy This Stock After a Regulatory Setback?
The Motley Fool via AOL· 18 hours agoSo, investors should expect solid clinical and regulatory progress moving forward for the biotech....
Many people quit new weight-loss drugs because of costs, side effects
UPI· 3 days agoReasons for quitting Wegovy, Ozempic or similar drugs may include cost or gastrointestinal side...
Regular fish oil use may harm those with healthy hearts
UPI· 5 days agoRegular use of fish oil supplements could increase the risk of first-time heart disease and stroke...
HPV vaccine linked to sharp reduction in risk of cancers in men
UPI· 2 days agoDevelopment and uptake of the human papilloma virus (HPV) vaccine has been crucial in reducing rates...
Nature Communications Publishes Pivotal Data Demonstrating Efficacy and Tolerability of CSL and...
The Yuma Sun· 7 days agoThe efficacy of ARCT-154 against severe COVID-19 was 100 percent in healthy persons aged 18-59 and more than 90 percent in persons at risk of severe consequences of the disease due...
As states loosen childhood vaccine requirements, public health experts’ worries grow
The State· 4 days agoLouisiana Republican state Rep. Kathy Edmonston believes no one ought to be required to vaccinate th...
Fed study offers new clues that help explain America’s gloomy mood
Yahoo Finance· 5 days agoMost experts think these huge variations come from on-and-off COVID stimulus, including the child...
Planning a DIY bathroom remodel or refresh? 9 reasons to include a bidet seat
Wisconsin State Journal· 3 days ago(BPT) - This renovation season, DIY projects are more popular than ever as people look to keep costs...
Here's Why Merck (MRK) Stock Has Outperformed Industry YTD
Zacks via Yahoo Finance· 7 days agoLigand beat estimates in each of the trailing four quarters, delivering an average surprise of...
Use of GLP-1 weight-loss drugs soars among teens, young adults
UPI· 4 days agoGLP-1 prescriptions among people ages 12 to 25 jumped by more than 594% (equivalent to a nearly...